Riverside agrees to sell HTBA to Miura Partners

HTBA is a specialty functional pharma, nutraceuticals and food ingredients business.

5 November 2024•2 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.